Revised Clinical Presentation of Parvovirus B19–Associated Intrauterine Fetal Death
Open Access
- 1 November 2002
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (9) , 1032-1038
- https://doi.org/10.1086/342575
Abstract
Adverse pregnancy outcome due to human parvovirus B19 (hereafter referred to as “parvovirus B19”) has been characterized, in numerous reports, as anKeywords
This publication has 22 references indexed in Scilit:
- Frequency of human parvovirus B19 infection in intrauterine fetal deathThe Lancet, 2001
- Determinants of unexplained antepartum fetal deathsPublished by Wolters Kluwer Health ,2000
- Pathogenesis of Nonimmune Hydrops Fetalis Caused by Intrauterine B19 InfectionThe Tohoku Journal of Experimental Medicine, 2000
- The changing panorama of late fetal death in Sweden between 1984 and 1991Acta Obstetricia et Gynecologica Scandinavica, 1999
- Risk Factors for Parvovirus B19 Infection in PregnancyJAMA, 1999
- Sixty‐six cases of intrauterine fetal deathActa Obstetricia et Gynecologica Scandinavica, 1995
- Risk of Adverse Outcomes of Pregnancy After Human Parvovirus B19 InfectionThe Journal of Infectious Diseases, 1988
- Weight-specific stillbirths and associated causes of death: An analysis of 765 stillbirthsAmerican Journal of Obstetrics and Gynecology, 1985
- Serologically proved intrauterine infection with parvovirus.BMJ, 1984
- INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALISThe Lancet, 1984